A phase two study of adults with moderate-to-severe atopic dermatitis shows that once-daily oral Janus kinase (JAK) 1 and 2 inhibitor baricitinib relieved itch and improved sleep, a study shows.
Moderate-to-severe psoriasis and psoriatic arthritis patients are more likely than people without these conditions to have cardiovascular and mental comorbidities, as well as higher healthcare utilization and medical costs, primarily from pharmacy-related expenses, according to a recent retrospective study of U.S. Department of Defense patients.
The risk of death for adults with psoriasis that impacts more than 10 percent of body surface area is about 1.8 times greater than adults without psoriasis, according to a new study.
Identifying associations with actinic keratosis variability instead of prevalence can be used to closely monitor organ transplant recipients at increased risk of developing actinic keratosis, researchers say.
Knowledge of outcomes data, adverse events may help physicians formulate effective treatment strategies, Dr. April Armstrong says.
Strong predictors for achieving a favorable actinic keratosis treatment response from ingenol mebutate 0.015% gel are dermoscopic detection of red pseudonetwork lesions and facial location, a study shows.
Physicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
The duration of methotrexate administration proves to be longer than that of cyclosporine in atopic dermatitis, according to a small study that compared the two first-line immunosuppressive treatments for atopic dermatitis.
During the American Academy of Dermatology’s annual meeting, physicians addressed the monumental changes that have occurred since the advent of biologic therapy for systemic autoimmune conditions, such as psoriasis and atopic dermatitis. Today, some patients are able to achieve complete disease clearance. Although there may be viable treatments for these conditions, access to care and medication adherence remain top issues, physicians say.
Multidisciplinary skin cancer care is an approach that might not only improve patient outcomes, but also professional satisfaction, researchers reported at AAD 2018 this week in San Diego.